1. Introduction
Charcot–Marie tooth (CMT) disease is one of the most common inherited peripheral neuropathies with a prevalence rate of 1/2500. It is clinically characterized by progressive muscle weakness and atrophy and can be classified by electrophysiological and histological criteria as demyelinating (CMT 1) or axonal (CMT 2) [
1]. Mutations in the protein Mitofusin-2 (MFN2), a GTPase of the outer mitochondrial membrane involved in mitochondrial fusion, causes the axonal subtype 2A which can be inherited in an autosomal-dominant and recessive manner. Regardless of the inheritance pattern or the clinical manifestation of the peripheral neuropathy, the testing for
MFN2 gene mutations has been recommended as a first-line analysis in the axonal subtype [
2].
The vital role of MFN2 or its close homologue MFN1 has been demonstrated in mice deficient in either of these mitofusins as it results in embryonic lethality during mid-gestation [
3]. MFN2 not only controls fusion of the outer mitochondrial membrane [
4] but also plays a critical role in the metabolic functions of mitochondria. Suppression of MFN2 expression reduces mitochondrial membrane potential, cellular respiration and mitochondrial proton leak [
5]. Conversely, overexpression of MFN2 increased cellular respiration even when expressed as a fusion-inactive deletion mutant [
6]. Others, including us, found increased cellular respiration in MFN2-deficient mouse embryonic fibroblasts (MEFs) compared to wildtype controls [
7,
8] and we recently reported that these discrepancies might be due to differences in redox conditions sensed by the thiol switch cysteine 684 [
8]. MFN2 is also a key determinant of so-called mitochondria-endoplasmic reticulum (ER) contact sites (MERCS), also known as mitochondria-associated membranes (MAMs), which represent hot spots of interactions and serve as important signaling hubs between these cellular organelles. MFN2 occurs on both sides of MAMs and apparently tethers the ER to mitochondria by homo- and heterotypic complexes with itself or its homologue MFN1 [
9]. This traditional view that lack of MFN2 loosens ER-mitochondria interaction and thereby mitigates the inositol-1,4,5-trisphosphate (IP3) receptor dependent Ca
2+ flux from the ER to mitochondria [
9], has, however, recently been challenged. By using elaborate electron microscopy techniques, Cosson et al. found increased ER-mitochondria juxtaposition in MFN2-deficient cells [
10], thus the opposite of what was previously thought. This was later reproduced using a whole array of different techniques and it was concluded that MFN2 rather works as a tethering antagonist preventing an excessive, potentially toxic proximity between the two organelles [
11]. However, even this was challenged and reduced levels of the mitochondrial Ca
2+ uniporter (MCU) were introduced as an additional complicating factor [
12]. It is probably safe to conclude that MFN2 is involved in MAM formation and integrity.
Züchner et al. were the first to identify a heterozygous 281G-A transition in the
MFN2 gene in a Russian kindred with CMT2A2A with an age of disease onset between 3 and 17 years [
13]. This mutation results in an arginine 94 to glutamine (R94Q) substitution in a helix bundle preceding the GTPase domain of the protein. Transgenic mice expressing this mutation in human MFN2 develop locomotor impairments and gait defects. This phenotype coincided with distal axon accumulation of mitochondria in the sciatic nerve [
14] and mitochondrial respiratory chain defects of complexes II and V associated with a drastic decrease of ATP synthesis [
15]. Using the same model and elaborate techniques to quantify mitochondrial ATP and hydrogen peroxide in resting or stimulated peripheral nerve myelinated axons in vivo, it was recently demonstrated that R94Q mitochondria fail to match the increased demand of ATP production in stimulated axons whereas the production of H
2O
2 was almost unaffected. The authors concluded that neuropathic conditions uncouple the production of reactive oxygen species (ROS) and ATP, thereby potentially compromising axonal function and integrity [
16]. Finally, R94Q MFN2 appears to lead to reduction in MERCS both in CMT2A patient-derived fibroblasts and primary neurons in vitro and in vivo in motoneurons of the above-mentioned mouse model of CMT2A [
17]. This was associated with increased ER stress, defective Ca
2+ handling, and alterations in the geometry and axonal transport of mitochondria [
17].
In this contribution, we studied mitochondrial shape, respiration, and mitochondrial quality control in MFN2-deficient fibroblasts stably expressing wildtype or R94Q MFN2. We found that mild oxidative stress induced by 24 h pretreatment with 100 µM hydrogen peroxide significantly increased respiration but decreased mitochondrial ATP generation in R94Q—but not in wildtype cells. This coincided with a defective PINK1/Parkin-mediated mitophagy. Our results suggest that the disease-causing R94Q mutation in MFN2 uncouples mitochondrial respiration from ATP production by a less efficient mitochondrial quality control under conditions of mild oxidative stress.
2. Materials and Methods
2.1. Cell Culture
Cell culture experiments were carried out with Mfn2
−/− and Mfn2
+/+ MEF [
3] kindly provided by Timothy Shutt (University of Calgary). Cells were grown according to standard methods under controlled conditions using in DMEM High Glucose (Sigma-Aldrich) supplemented with 10% (
v/v) fetal calf serum (FCS, Thermo Scientific, Waltham, MA, USA), 100 U/mL penicillin and 100 µg/mL streptomycin (Thermo Scientific, Waltham, MA, USA) at 37 °C in a humidified incubator (5% CO
2). The PiggyBac system was used to create cells stably expressing HA-MFN2-IRES-mCherry-NLS constructs followed by enrichment of mCherry-positive cells using fluorescence-activated cell sorting essentially as described [
18].
2.2. Immunoblotting
Cell were lysed with RIPA buffer and subjected to SDS-Page and immunoblotting according to standard methods essentially as described [
8,
19]. Primary antibodies were anti-MFN2 mAB (1:500; Abnova, Taipei City, Taiwan), anti-G6PD (1:1000; Cell Signaling, Danvers, MA, USA), anti-PKM1/2 (1:1000; Cell Signaling), anti-Hexokinase I (1:1000; Cell Signaling), anti-Hexokinase II (1:1000; Cell Signaling) and anti-Actin mAB (1:4000; Merck Millipore, Burlington, MA, USA). Protein bands were revealed and analyzed following incubation for 1 h at room temperature with a secondary goat anti-mouse IgG antibody conjugated to an infrared fluorescent dye (IRDye 800, Licor, Bad Homburg, Germany) using the Odyssey near infrared laser imaging system (Licor, Bad Homburg, Germany). For mitophagy induction, cells were treated with 10 µM carbonyl cyanide 3-chlorophenylhydrazone (CCCP) for the indicated time under normal culturing conditions. The reaction was stopped by washing steps with PBS and cell lysis with RIPA buffer.
2.3. Measurement of Mitochondrial Oxygen Consumption
Intact MEF cells were monitored for mitochondrial oxygen consumption using a high-resolution respirometer (Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria) as previously described [
8,
19] using identical substrates and inhibitors purchased from Sigma-Aldrich (St. Louis, MO, USA). Briefly, after recording routine respiration, ATP synthase activity was inhibited by 2.5 µM oligomycin to determine leak respiration. Stepwise addition of 0.5 µM carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) was performed to reveal the maximum capacity of the electron transfer system (ETS). Non-mitochondrial residual oxygen consumption (ROX) was determined following inhibition of respiration by application of 0.5 µM rotenone and 2.5 µM antimycin A. Mitochondrial respiration changes in response to redox alterations were examined after 24 h pretreatment of cells with 100 µM hydrogen peroxide (H
2O
2)
. All experiments were carried out after correction of instrumental background and calibration of the polarographic oxygen sensors. Data analysis was done using the DatLab Software 5.1 (Oroboros Instruments, Innsbruck, Austria) as described [
8,
19] and all values were corrected for ROX and instrumental background.
2.4. Cell Proliferation Assay
MEF cells were seeded into white 96-well plates at a density of 750 cells/well. The same day, NanoLuc luciferase and substrate (G9711, Promega, Madison, WI, USA) were added simultaneously to the cell culture media. Metabolically active cells can reduce the substrate, which in turn can react with the luciferase. Total luminescence was directly measured using the Infinite 2000 Pro microplate reader (Tecan, Männedorf, Switzerland). After 24 h, the luminescence was measured a second time and the cells were treated with 100 µM H2O2. The luminescence was measured again after 24 h and 48 h. Data are expressed as proliferation rate normalized to the first day (proliferation rate = 0).
2.5. Quantification of ATP Levels
Relative ATP levels were determined with BTeam, a BRET-based ATP biosensor [
20]. MEF cells were seeded into white 96-well plates at a density of 2000 cells/well and transfected 24 h later using TurboFectin reagent (OriGene, Rockville, MD, USA) with BTeam lacking a targeting sequence (for cyto-ATP determination) or containing a mitochondrial targeting sequence (for mito-ATP determination). After 24 h, cells were treated with H
2O
2 for additional 24 h and then incubated for 30 min in phenol red-free DMEM containing 10% FBS, and 30 µM NanoLuciferase (NLuc) inhibitor to prevent unintended detection of BTeam released from dead cells. Cells were subsequently incubated for 20 min in the presence of NLuc substrate (Promega, Madison, WI, USA) and the luminescence was measured at 520/60 nm (ex/em) (Yellow Fluorescent Protein (YFP) emission) and at 430/70 nm (ex/em) (NLuc emission) at 37 °C. Data are expressed as YFP/NLuc emission ratio.
2.6. Measurement of Total Cellular GSH
Cells were plated in a 6-well plate at a density of 200,000 cells/well, treated 24 h later for two different time periods (2 h and 24 h) with 100 µM H2O2. Cells were washed twice with ice-cold PBS and resuspended in 200 µL SSA/HCl buffer containing 1.3% w/v sulfosalicylic acid and 8 mM HCl in KPE buffer. For KPE buffer, 0.1 M solutions of KH2PO4 and K2HPO4 were prepared; 16 mL and 84 mL of these solutions were mixed respectively with 5 mM EDTA in order to obtain 100 mL of a 0.1 M phosphate buffer with a pH of 7.5. Samples were vortexed and incubated on ice for 10 min and centrifuged at 14,000 rpm for 10 min. The pellet was resuspended in 0.2 N NaOH and incubated at 37 °C overnight, followed by protein quantitation (BC Assay, Interchim). The supernatant was split into two new microcentrifuge tubes containing 12 µL of triethanolamine/H2O 1:1, for GSH and GSSG quantification. 2 µL of 2-Vinylpyridine (2-VP, Sigma-Aldrich, prediluted 1:5 in EtOH) was added to the GSSG tubes and incubated on ice and in the dark for one hour. GSH was then measured by monitoring NADPH consumption by GSH reductase in KPE assay buffer, containing 2.8 mM DTNB (5,5′-dithiobis-(2-nitro-benzoic acid)) and 1.3 mM NADPH, at 390 nm using the Infinite 2000 Pro microplate reader (Tecan, Männedorf, Switzerland) and the SpectraMax I3 microplate reader. The same assay procedure was carried out for the 2-VP treated GSSG samples and the final GSH/GSSG concentrations were normalized to the total protein amount. All chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA).
2.7. Lactate Measurement
Cells were plated in a 6-well plate at a density of 200,000 cells/well and treated after 24 h with H2O2 for additional 24 h. A minimum of 200 µL of the culture medium was removed for lactate quantification, which was performed by using the Alinity Lactic Acid Reagent Kit (8P2120, Abbott, Chicago, IL, USA) following the manufacturers’ instructions. The reaction was measured photometrically with the Alinity c analyzer (Abbott, Chicago, IL, USA). Measured lactate concentrations were normalized to the total protein amount per well.
2.8. RNA Isolation and PCR
Cells were treated with 100 µM H2O2 for 24 h. RNA of cells was prepared using the ZR RNA MiniPrep™ kit from Zymo Research (R1064, Irvine, CA, USA) following manufacturers’ instructions. RNA was reversed transcribed using the cDNA synthesis kit (Life Technologies, 4368814). Quantitative real-time PCR was performed with the 7500 Real-Time PCR Systems device (Applied Biosystems, Foster City, CA, USA) using FAM/Dark quencher probes from the Universal Probe Library™ (Roche, Basel, Switzerland). The expression was quantified to the relative levels of the housekeeping gene hypoxanthineguanine phosphoribosyltransferase (HPRT), which was assessed by FAM-TAMRA probe FAM-CCTCTCGAAGTGTTGGATACAGGGCA-TAMRA and the primers forward GTTGCAAGCTTGCTGGTGAA and reverse GATTCAAATCCCTGAAGTACTCA. For amplification and detection of glutamate-cysteine ligase, catalytic subunit (GCLc), glutathione S transferase omega 1 (GSTO1), NADPH-quinone-oxidoreductase-1 (NQO1), glutathione peroxidase 1 (GPX1), heme-oxygenase-1 (HO1) and cystine/glutamate transporter (xCT) the following primers were used: xCT: forward TGGGTGGAACTGCTCGTAAT, reverse AGGATGTAGCGTCCAAATGC, probe 1 (Universal Probe Library™, Roche). GCL forward GGAGGCGATGTTCTTGAGAC, reverse CAGAGGGTCGGATGGTTG probe 2 (Universal Probe Library™, Roche). GST1 forward CAGCGATGTCGGGAGAAT, reverse GGCAGAACCTCATGCTGTAGA, probe 60 (Universal Probe Library™, Roche). GPX1: forward TTTCCCGTGCAATCAGTTC, reverse TCGGACGTACTTGAGGGAAT, probe 2 (Universal Probe Library™, Roche). HO1: forward GTCAAGCACAGGGTGACAGA, reverse ATCACCTGCAGCTCCTCAAA, probe 4 (Universal Probe Library™, Roche). NQO1: forward AGCGTTCGGTATTACGATCC, reverse AGTACAATCAGGGCTCTTCTCG, probe 50 (Universal Probe Library™, Roche, Basel, Switzerland). RNAse-free water was used as the non-template control. Analysis of the results was performed using the ΔΔCT-method. All conditions were normalized to their untreated control group.
2.9. Microscopy and Image Analysis
For microscopic image analysis, cells were plated into 8-well-glass-bottom slides (IBIDI, Gräfelfing, Germany) to reach a final cell confluency of 60–80% on the day of image acquisition. Cells were exposed to 100 µM H2O2 or vehicle 24 h before image recording. Image acquisition was done with the confocal microscope Leica TCS SP5 (Leica Microsystems, Wetzlar, Germany) using a 63× oil immersion objective. For mitochondrial morphology analysis, cells were seeded as described above, cultured for 24 h in serum-supplemented medium and incubated for 15 min with 0.2 μM MitoTracker Red CMXRos (Invitrogen, Carlsbad, CA, USA) in serum-free medium. Cells were washed once with PBS (Sigma-Aldrich) and further incubated for 15 min in serum-supplemented medium. Live cell imaging was performed with an ex/em of 560/610 nm. Cells were categorized according to their mitochondrial morphology (tubular, mixed or fragmented) and analyzed by observers blind to the experimental conditions and genotypes.
Cellular ROS was analyzed by staining with the CellROX reagent (Molecular Probes, Eugene, OR, USA) in a final concentration of 5 µM for 30 min at 37 °C. After thoroughly washing with PBS, pre-warmed DMEM without phenol red (Thermo Scientific) was added and the fluorescence intensity was measured at 485/520 nm (ex/em). For glucose uptake measurement, cells were plated into 8-well-glass-bottom slides (IBIDI, Gräfelfing, Germany). Next day, cells were treated with 100 µM H2O2 or vehicle for 24 h before cells were incubated with the fluorescent d-glucose analog 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose (2-NBDG) (Thermo Scientifc) at a final concentration of 100 µM for 60 min at 37 °C. After washing with PBS for two times, pre-warmed DMEM without phenol red (Thermo Scientific) was added and the fluorescence intensity was measured at 465/540 nm (ex/em) and analyzed with ImageJ (Fiji). Transfections were performed with Lipofectamine 2000 reagent (Thermo Scientific) according to manufacturers’ instructions. Briefly, 100 µL and 125 µL Opti-MEM (Gibco Life Technologies, Waltham, MA, USA) was mixed with 8 µL Lipofectamine and 2.5 µg DNA, respectively. Subsequently, 90 µL of each solution was mixed and incubated for 5 min at room temperature before 10 µL was added to each well. Image recording was carried out 48 h after transfection. Cells were transfected with Mt-Keima (kind gift of Atsushi Miyawaki, RIKEN Brain Science Institute, Japan) or Mito-Timer (Addgene, Watertown, NY, USA). 24 h after H2O2 treatment for Mt-Keima the intensities of the fluorescence at 620 nm were captured when excited at 550 nm and 438 nm. The intensity was analyzed using ImageJ (Fiji), selecting the cytoplasm of the cells using regions of interest outside the nucleus and then analyzing the mean intensity. The intensity at 550 nm was normalized to the intensity at 438 nm. For Mito-Timer, fluorescence intensity was measured at 561/572 nm (ex/em) and 488/518 nm (ex/em). For measurement of the colocalization of GFP-Parkin (kind gift of Julia Fitzgerald, University of Tübingen, Germany) and Mito-TurboFarRed the fluorescence intensity was measured at 488/518 nm (ex/em) for GFP-Parkin and at 633/640 nm (ex/em) for Mito-TurboFarRed. Parkin-Mito-TurboFarRed colocalization was measured using the JACoP plugin of ImageJ (Fiji).
2.10. Statistical Analyses
Statistical analyses were conducted using GraphPad Prism (GraphPad). The respective statistical tests are mentioned in the figure legends. Statistically significant differences were assumed with p < 0.05.
4. Discussion
We here investigated how a mutation in MFN2 that causes neuronal degeneration of peripheral motoneurons in the hereditary polyneuropathy CMT2A alters key characteristics of mitochondria-like shape, respiration and ATP generation under optimal culture conditions and after a single exposure to mild oxidative stress. Interestingly, under optimal culture conditions only mitochondrial shape was affected by the mutation; R94Q cells had more fragmented mitochondria at baseline. The additional challenge with a low dose of hydrogen peroxide however unmasked additional and probably relevant changes of respiration and mitochondrial ATP generation. Oxidative challenge triggered the mitochondria of cells expressing the R94Q variant of MFN2 but not wildtype to produce less ATP despite an increased oxygen consumption which coincided with an even more fragmented mitochondrial shape. This additional stress thus caused these mutant mitochondria to behave like cells completely lacking MFN2 where mitochondrial respiration was also found to be increased (see
Figure 1c and data shown previously [
7,
8]). It needs to be pointed out, however, that others reported a reduced mitochondrial membrane potential, cellular respiration and leak after down-regulation by antisense oligonucleotides in myoblasts [
5] or in heart mitochondria obtained from MFN2−/− mice. This is possibly because these studies were done in skeletal and heart muscle, in tissue and cells, respectively. Interestingly, the cysteine switch C684A which seems to be implicated in mitochondrial hyperfusion, a cellular stress response program, does not mediate the response to oxidative stress in this case as experiments exposing mitochondria to glutathione which attenuates respiration in C684A cells [
8] had no effect in the CMT2A-R94Q cells. However, oxidative signaling does not only result in direct modification of so-called thiol switches, reversible modifications of cysteine thiols that play a key role in redox signaling and regulation [
30,
31], but can also generate second messengers such as 4-hydroxynonenal (HNE), an amphipathic molecule that is generated in response to lipid oxidation which can covalently modify residues in many proteins in different cellular compartments including mitochondria [
32]. An effect of HNE on MFN2 has however not been reported yet.
Using mice expressing the R94Q mutation in neurons—of course a much better model of the disease—others observed a combined defect of mitochondrial complexes II and V associated with a drastic decrease of ATP synthesis caused by succinate oxidation [
15]. Interestingly, these changes could be reversed by the inhibition of mitochondrial ATP-sensitive potassium channels with 5-hydroxydecanoate [
15]. Maybe the hydrogen peroxide challenge affected succinate oxidation. Others also reported that R94Q mitochondria failed to up-regulate ATP production following burst neuronal activation [
16]. In wildtype neurons, a first burst generated a H
2O
2 but no ATP peak and a second burst applied 30 min later generated a second H
2O
2 peak followed by an ATP rise 20 min later. In neurons from R94Q mice, this ATP peak was greatly attenuated [
16] which is in line with our findings that prior H
2O
2 exposure affects ATP production.
In our cells, the mitochondrial uncoupling of ATP generation and respiration triggered by mild oxidative stress coincided with an altered mitochondrial quality control. We observed a less efficient degradation of MFN2 upon membrane dissipation which is generally attributed to the PINK1/Parkin pathway and less Parkin colocalization with mitochondria under steady-state conditions. It was previously shown that PINK1 phosphorylates MFN2 and promotes Parkin-mediated ubiquitination and subsequent degradation [
33]. In these experiments, accumulation of morphologically and functionally abnormal mitochondria in MFN2-deficient MEFs induced respiratory dysfunction [
33] similar to our observations. Interestingly, loss of Beclin-1, an important autophagy protein involved in autophagosome formation and maturation, inhibits CCCP-induced Parkin translocation to mitochondria and MFN2 ubiquitination and degradation [
34]. Surprisingly, Beclin-1 depletion also rescued the suppression of mitochondrial fusion in MFN2-deficient cells [
34] suggesting that MFN2 mutation may somehow affect this pathway although this is difficult to fathom. Alternatively, the mutation could affect phosphorylation of MFN2 by PINK1 required for Parkin binding and mitochondrial Parkin translocation which suppresses mitophagy, however, without impairing mitochondrial fusion [
35]. It must be mentioned that others found enhanced, thus not decreased, mitophagy in motoneurons from induced pluripotent stem cells obtained from patients with CMT2A. This observation was accompanied by global reduction in mitochondrial content and changes in mitochondrial positioning without significant differences in survival and axon elongation [
36]. These patient-derived neurons show an increased expression of PINK1, PARK2, BNIP3, and a splice variant of BECN1 that appears to be a trigger for mitochondrial autophagic removal [
36]. It is possible that this splice variant is only expressed in human motoneurons thus explaining the opposite findings. This view is strengthened by the findings that MFN2 deficiency in mouse muscle reduced autophagy and impaired mitochondrial quality thus contributing to an exacerbated age-related mitochondrial dysfunction [
37]. Similar to our findings where the R94Q cells had less reactive oxygen levels under optimal conditions, these authors found that aging-induced Mfn2 deficiency triggers a ROS-dependent adaptive signaling pathway by induction of the HIF1α transcription factor and BNIP3 which may compensate for the loss of mitochondrial autophagy and thereby protect mitochondria [
37]. Yet others proposed that different levels of MFN1, a close homologue of MFN2, could alter the effect of mutant R94Q MFN2 on Parkin-mediated mitochondrial degradation indicating that augmentation of MFN1 in the nervous system could be a viable therapeutic strategy for CMT disease [
38].